Trial record 1 of 1 for:    NCT01553149
Previous Study | Return to List | Next Study

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

This study has suspended participant recruitment.
(Temporarily stopped for assessment.)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: March 10, 2012
Last updated: October 9, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)